Application of trioxy rectal perfusion therapy in laparoscopic surgery under ERAS concept

Application of preoperative trioxy rectal perfusion pretreatment in laparoscopic surgery

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400090656

Enrollment

Unknown

Registered

2024-10-11

Start date

2024-10-15

Completion date

Unknown

Last updated

2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute postoperative pain

Interventions

Trioxy rectal perfusion group (T group):Inject 150mL of trioxy gas into the rectum (concentration 30µg/mL)

Control group (Group C):Place the hose 10 to 12cm into the rectum without injecting any gas

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ?No such surgery had been performed in the 3 months prior to the trial. ?The American Society of Anesthesiologists (ASA) has a grade I to II. ?Sign informed consent and agree to postoperative follow-up. ? Patients undergoing elective laparoscopic surgery. . . . . .

Exclusion criteria

Exclusion criteria: ?There is contraindication of trioxy rectal perfusion. ?History of allergy to the drugs used in this study. ?Severe lung, brain, liver, renal insufficiency. ?A history of drug addiction. ?Taking sedatives or antidepressants. ?Suffers from central nervous system disease.

Design outcomes

Primary

Measure	Time frame
visual analogue scale, VAS;	—

Secondary

Measure	Time frame
Quality of Recovery-15;Postoperative analgesic drug use;	—

Countries

China

Contacts

Public ContactFang Ming

Affiliated Hospital of Jiangnan University

forlavi@vip.163.com+86 153 0151 6690

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026